
Werner Wenning proposed as chairman of the supervisory board at Bayer
pharmafile | February 24, 2012 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing |ย ย Bayer, Schneider, Wenningย
Former Bayer chief executive Werner Wenning is set to be elected to the supervisory board at Bayer with effect from October.
His planned return to Bayer would see him succeed Dr. Manfred Schneider as chairman of the supervisory board as of that date.
Schneider would remain a member of the supervisory board and its chairman until September, and then be succeeded by Wenning, who would join the supervisory board and become its chairman for the remainder of the term until 2017.
Wenning, 65, was chairman of the board of management of Bayer from April 2002 until September 2010. The statutory โcooling-off period,โ after which former members of a companyโs board of management may join its supervisory board, ends after two years.
Related Content

Evotec and Bayer announce new kidney disease study
Evotec and Bayer have announced the initiation of a phase 2 clinical study in kidney …

Third application for Orionโs prostate cancer drug submitted by partner Bayer
Finnishย pharmaceutical company Orion has announced that its partner Bayer is applying for a third application …

Bayer and Evotec to collaborate on precision cardiology
Bayer and Evotec have announced that they have updated the focus of their collaboration to …






